Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients

Neuropsychobiology. 2008;57(3):139-45. doi: 10.1159/000142361. Epub 2008 Jul 7.

Abstract

Introduction: Recent post-mortem studies of suicide victims have implicated brain-derived neurotrophic factor (BDNF) in suicide. Therefore, it was decided to examine the possible role of a gene in the regulation of BDNF activity in relation to suicidal behaviour among depressed patients.

Method: A series of 170 depressed patients were evaluated for their history of suicide attempts and genotyped for the BDNF Val66Met polymorphism (SNP ID: rs6265). Depressed patients who had (n = 97) or had not (n = 73) attempted suicide were compared.

Results: Depressed patients who carried the BDNF Val66Met polymorphism variant (GA + AA) appeared to show a significantly increased risk of suicidal behaviour. The risk of a suicide attempt was also significantly higher among those reporting higher levels of childhood emotional, physical and sexual abuse. Secondary analyses suggested that depression severity was a significant risk factor only in the wild-type BDNF genotype, and that the risk of suicide attempts was more predictable within the wild-type group.

Conclusion: These preliminary data suggest that BDNF may play a role in the suicidal behaviour of depressed patients.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Adult Survivors of Child Abuse / psychology*
  • Amino Acid Substitution
  • Brain-Derived Neurotrophic Factor / genetics*
  • Chi-Square Distribution
  • Depressive Disorder, Major / genetics*
  • Depressive Disorder, Major / psychology
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide
  • Suicide, Attempted / psychology*

Substances

  • Brain-Derived Neurotrophic Factor